Oncology

The MSc in Oncology at the University of Oxford is a comprehensive and rigorous programme designed to provide students with an in-depth understanding of the fundamental principles, latest research, and clinical applications of cancer biology and treatment. This programme aims to equip graduates with the knowledge and skills necessary to contribute effectively to the fields of cancer research, clinical oncology, and healthcare policy. Throughout the course, students explore a wide range of topics including tumor biology, cancer genetics, molecular mechanisms of carcinogenesis, and advances in targeted therapies and immunotherapy. The curriculum integrates both theoretical foundations and practical approaches, ensuring learners are well-prepared for research, clinical practice, or further academic study. The programme is delivered by leading experts in Oncology and related disciplines, often involving seminars, workshops, and opportunities for clinical exposure. Students also participate in research projects, fostering critical thinking, experimental design, and data analysis skills. The MSc in Oncology encourages an interdisciplinary approach, collaborating with specialists in molecular biology, genetics, pharmacology, and clinical medicine, reflecting the collaborative nature of modern cancer care and research. Admission is competitive and requires a strong academic background in biological sciences or related fields. Graduates of the programme have gone on to pursue careers in academic research, clinical trials, healthcare policy, pharmaceutical industries, and academic medicine. The University of Oxford's state-of-the-art facilities, world-class faculty, and extensive research networks provide an enriching environment for students committed to advancing cancer understanding and treatment. This programme offers not only a solid academic foundation but also opportunities for professional development and networking within the global oncology community.

Applicants are strongly advised to visit the Medical Sciences Graduate School website to help them identify the most suitable course and supervisors.

You can contact the supervisors listed against currently available research projects for more information.

The department covers research in the following areas:

• biochemistry of base excision repair
• molecular determinants of radiosensitivity
• tumour stroma interactions in radiobiology
• molecular imaging
• DNA damage response to the tumour microenvironment
• DNA damage signalling
• chromosome integrity
• molecular resistance to treatments
• mechanisms of metastasis
• tumour suppressor signalling
• radiation-induced DNA damage and response
• DNA adduct repair
• telomeres and genome stability
• experimental radiation therapeutics
• advanced imaging technology
• angiogenesis and hypoxia, role of miRNA
• cancer and immunogenetics
• cancer predisposition disorders and pharmogenetics
• HPV, apoptosis and cancer
• insulin-like growth factors
• tumour growth control
• gene therapy in particular virotherapy of advanced cancer
• cancer in the developing world

Applicants are normally expected to be predicted or have achieved a first-class or strong upper second-class undergraduate degree with honours (or equivalent international qualifications), as a minimum, in a biological, medical, chemical, mathematical and physical science background, as appropriate for the projects offered.

For applicants with a degree from the USA, the minimum GPA sought is 3.5 out of 4.0.

If you hold non-UK qualifications and wish to check how your qualifications match these requirements, you can contact the National Recognition Information Centre for the United Kingdom (UK NARIC).

No Graduate Record Examination (GRE) or GMAT scores are sought.

However entrance is highly competitive and most successful applicants have a first-class degree or the equivalent. A previous master's degree is not required, but is an advantage.

• Official transcript(s)
• CV/résumé
• Personal statement: 1,000 words
• References/letters of recommendation:Three overall, generally academic

ENGLISH LANGUAGE REQUIREMENTS

Higher level

Financing studies at the University of Oxford for the Oncology program involves a variety of funding options designed to assist eligible students in covering tuition fees and living expenses. The university offers an extensive range of scholarships, bursaries, and financial aid packages tailored to both domestic and international students. Prospective students are encouraged to explore scholarship opportunities such as the Clarendon Fund, which provides full and partial funding to various graduate students across disciplines, including Oncology. Additionally, departmental-specific scholarships may be available based on academic merit or financial need.

Students can also apply for external funding sources, including government-sponsored loans, private scholarships, and research council grants relevant to their nationality and academic background. The university's financial aid office provides comprehensive guidance and support in navigating these options, including eligibility criteria and application procedures. For international students, the university may offer limited scholarships or financial aid packages, but applicants are advised to consider external funding sources as well.

Living costs in Oxford vary depending on accommodation choices and personal lifestyle, ranging from approximately £11,000 to £15,000 per year, which students should consider when planning their finances. Tuition fees for the Oncology program are set annually and differ for home and international students; currently, domestic students benefit from government-subsidized fees, while international students are required to pay higher tuition rates.

Students are also encouraged to explore part-time work opportunities on campus or internships related to their field of study to supplement financial support. The university’s finance office provides detailed information on budgeting and financial planning throughout the course duration. Overall, students are advised to apply early, leverage available scholarships, seek external funding sources, and plan their finances meticulously to ensure a smooth academic experience.

The MSc in Oncology at the University of Oxford offers an in-depth exploration of the fundamental principles and latest advances in cancer biology, diagnosis, and treatment. This program is designed for students with a background in biomedical sciences, medicine, or related disciplines who wish to develop a comprehensive understanding of oncological sciences and research. Over the course of the program, students engage with a diverse curriculum that covers molecular mechanisms of cancer, clinical oncology, cancer genetics, immunology, and targeted therapies. The program includes taught modules, practical laboratory work, and opportunities for research projects, enabling students to acquire both theoretical knowledge and practical skills essential for a career in cancer research or clinical practice.

Students benefit from Oxford’s world-class research facilities and close interactions with leading experts in the field of oncology. The program emphasizes an interdisciplinary approach, integrating insights from molecular biology, clinical practice, and translational research. This prepares graduates to contribute effectively to the development of innovative cancer treatments and policy. The MSc typically spans one year full-time or can be undertaken part-time, allowing flexibility for working professionals. Assessment methods include written examinations, research projects, presentations, and coursework, all designed to evaluate students’ understanding and research capability.

Graduates of this program are well-equipped to pursue careers in academic and clinical research, pharmaceutical development, cancer healthcare provision, or further postgraduate study such as a PhD. The program also offers networking opportunities through seminars, workshops, and conferences, fostering collaborations within the cancer research community. The overall aim of the MSc in Oncology is to produce highly skilled professionals who can contribute to improving cancer diagnosis, treatment strategies, and patient outcomes, in line with Oxford’s commitment to advancing medical science and health care.